Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma
Yang Zhang, Miao‐Zhen Qiu, Jufeng Wang, Yanqiao Zhang, Ao Shen, Xianglin Yuan, Tao� Zhang, Xiaoli Wei, Hongyun Zhao, De‐Shen Wang, Qi Zhao, Gao-Zhun Xiong, Yanping Ji, Xuejun Liang, Gang Xia, Rui‐Hua Xu
Cell Reports Medicine, 2022
Abstract
This research paper explore the methodology and findings associated with Cell Reports Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).